{"schemaVersion":1,"profileUrl":"https://nowen.ai/agents/epii-com","markdownUrl":"https://nowen.ai/agents/epii-com.md","jsonUrl":"https://nowen.ai/agents/epii-com.json","name":"Electromedical Products International, Inc.","nickname":"EPI","website":"https://epii.com","industry":"Medical Devices","status":{"trust":"unclaimed","text":"Unclaimed: compiled by Nowen from public sources, not reviewed by the company"},"updatedAt":"2026-09-06T23:19:22.781Z","summary":"Electromedical Products International, Inc. (EPI) is a global medical device company delivering non-invasive neuromodulation therapies for anxiety, insomnia, depression, and pain.","description":"Electromedical Products International, Inc. (EPI) is a global medical device company focused on non-invasive neuromodulation therapeutics. It develops safe, drug-free solutions that aim to alleviate anxiety, insomnia, depression, and pain. The company advances brain stimulation research and collaborates with clinicians and researchers to bring evidence-based therapies to patients and healthcare professionals worldwide.","mission":"At EPI, we are pioneers in innovative neuromodulation therapeutics, dedicated to transforming healthcare through advanced, non-invasive solutions. Our mission is to harness the power of cutting-edge technology and evidence-based science to develop safe and effective therapies that improve lives.","directory":{"industryName":"Medical Devices","agentCount":21,"indexable":true,"hubUrl":"https://nowen.ai/industry/medical-devices"},"aiReaderFamilies":["Anthropic","Amazon"],"products":[{"name":"Alpha-Stim","type":"Product","url":"https://alpha-stim.com/","summary":"Provides rapid, safe, and effective treatment for anxiety, insomnia, and pain.","description":"Alpha-Stim is a drug-free, non-invasive medical device that delivers cranial electrotherapy stimulation (CES) to treat anxiety and insomnia and microcurrent electrical therapy (MET) to relieve pain. It is FDA-cleared and available over the counter in many countries; in the US, a prescription is required. Alpha-Stim includes the functionalities of Alpha-Stim M and Alpha-Stim AID, offering a comprehensive therapeutic solution for both pain and mental health issues, complemented by the AS-Trode Silver Electrode Pads for enhanced pain management.","pricing":{},"features":[{"name":"CES via earclip electrodes","value":"Delivers Effective CES","valueDescription":"Targets brain activity associated with anxiety and insomnia through cranial electrotherapy stimulation."},{"name":"Drug-free, non-invasive therapy","value":"Offers Safe Treatment","valueDescription":"Provides effective treatment options without the risks associated with pharmaceuticals."},{"name":"FDA clearance","value":"Ensures Regulatory Compliance","valueDescription":"Backed by FDA approval, ensuring safety and effectiveness in treatment."},{"name":"Patented waveform","value":"Utilizes Advanced Waveform Technology","valueDescription":"Employs a proprietary waveform that enhances treatment efficacy by stimulating brain activity."},{"name":"Personalized Treatment","value":"Customizes Therapy Sessions","valueDescription":"Enhances treatment outcomes by tailoring the neurostimulation to individual patient needs and responses."},{"name":"Pain, Anxiety, Insomnia Targets","value":"Addresses Multiple Health Concerns","valueDescription":"Effectively targets pain relief, anxiety management, and insomnia treatment, promoting overall wellness."},{"name":"MET via handheld probes","value":"Achieves Targeted Pain Relief","valueDescription":"Effectively reduces pain by delivering targeted microcurrents directly to affected areas."},{"name":"Global availability","value":"Accessible Worldwide","valueDescription":"Readily available for purchase in various markets, facilitating widespread access to effective therapy."},{"name":"AS-Trode Compatibility","value":"Enhances Treatment Options","valueDescription":"Allows for effective treatment of acute, chronic, and post-traumatic pain through innovative AS-Trode silver electrode pads."}]},{"name":"XCSITE-RD","type":"Platform","url":"","summary":"Provides a potent research platform for non-invasive brain stimulation technologies.","description":"XCSITE-RD is a non-invasive brain stimulation research platform capable of delivering high-powered tACS, tDCS, and custom waveform stimulation; portable and easy to use, with double-blind capable software featuring active-sham and multiple study management.","pricing":{},"features":[{"name":"Double-blind capable software","value":"Enhances Study Validity","valueDescription":"The double-blind capable software increases research reliability by minimizing bias through active-sham controls."},{"name":"tACS, tDCS, and custom waveform stimulation","value":"Targets Brain Activity Precisely","valueDescription":"Offers various stimulation types to target specific brain activities, enhancing treatment personalization and effectiveness."},{"name":"Portability and ease of use","value":"Facilitates Research Anywhere","valueDescription":"The lightweight and user-friendly design allows researchers to conduct studies in diverse settings without complicated setups."}]},{"name":"Closed-Loop tACS Device","type":"Product","url":"https://epii.com/breakthrough-device/","summary":"Provides rapid, personalized relief from Major Depressive Disorder symptoms through innovative brain stimulation.","description":"Pulvinar Neuro's Closed-Loop Transcranial Alternating Current Stimulation (tACS) device is designed to treat Major Depressive Disorder. It provides personalized brain stimulation based on real-time brain activity and aims to deliver rapid relief, as part of a drug-free neuromodulation approach.","pricing":{},"features":[{"name":"FDA Breakthrough Device designation","value":"Accelerates Access to Patients","valueDescription":"The designation recognizes the device's potential to significantly improve treatment for Major Depressive Disorder, facilitating quicker availability for patients."},{"name":"Personalized brain stimulation","value":"Adapts to Brain Needs","valueDescription":"Utilizes real-time data to customize stimulation, targeting specific disruptions related to depressive symptoms for greater efficacy."},{"name":"Rapid Relief from Symptoms","value":"Achieves Quick Recovery","valueDescription":"Clinical trials show significant symptom reduction in patients, with many reporting freedom from depressive symptoms shortly after treatment."},{"name":"Adjunct to standard care","value":"Enhances Treatment Efficacy","valueDescription":"Utilized as an addition to standard therapy, improving treatment outcomes for patients with Major Depressive Disorder."}]}],"audiences":[{"title":"Academic Medical Centers And Research Institutions","description":"Research-focused hospitals and universities pursuing neuromodulation trials.","industries":["Healthcare","Academic Research","Biotech"],"geography":"North America, Europe","painPoints":"Need robust, evidence-based neuromodulation devices for trials; ensure data integrity; meet regulatory requirements; coordinate multi-site studies.","businessGoals":"Advance neuromodulation research; publish results; secure funding; expand multi-site studies.","positioningStatement":"Non-invasive neuromodulation solutions that support rigorous research, rapid study setup, and high-quality data across multi-site trials."},{"title":"Private Mental Health And Sleep Clinics","description":"Outpatient clinics seeking drug-free neuromodulation for anxiety and insomnia.","industries":["Healthcare","Mental Health","Sleep Medicine"],"geography":"North America, Europe","painPoints":"Limited non-drug treatment options; payer reimbursement navigation; patient adherence","businessGoals":"Improve patient outcomes; differentiate services; expand offerings","positioningStatement":"Drug-free neuromodulation therapies that clinics can integrate to improve outcomes in anxiety and insomnia."},{"title":"Pain Management Clinics","description":"Clinics focusing on chronic pain with non-drug options.","industries":["Healthcare","Pain Management"],"geography":"North America, Europe","painPoints":"Chronic pain burden; opioid-sparing requirements; patient expectations","businessGoals":"Reduce pain scores; minimize opioid use; improve patient throughput","positioningStatement":"Non-invasive neuromodulation to complement pain management programs with easy adoption and patient-friendly therapy."},{"title":"Neuromodulation Research Laboratories And Clinical Trial Partners","description":"Research labs and CROs advancing neuromodulation research and multi-site trials.","industries":["Clinical Research","Healthcare Technology"],"geography":"Global","painPoints":"Need double-blind capable tools, complex study management, data integration","businessGoals":"Streamline neuromodulation studies, improve data quality, accelerate insights","positioningStatement":"End-to-end research platforms enabling double-blind trials, high data integrity, and efficient multi-site neuromodulation studies."}],"segments":[{"name":"At-home cranial electrotherapy devices","description":"Devices delivering cranial electrotherapy stimulation (CES) for self-administered treatment of anxiety and insomnia; available OTC in some markets and by prescription in others.","color":1,"productNames":["Alpha-Stim"]},{"name":"Microcurrent pain therapy devices","description":"Portable microcurrent electrical therapy (MET) systems and electrode accessories for non-opioid management of acute and chronic pain in outpatient and home settings.","color":2,"productNames":["Alpha-Stim"]},{"name":"Closed-loop transcranial stimulation for major depressive disorder","description":"Personalized closed-loop transcranial alternating current stimulation (tACS) systems intended to augment standard care and provide rapid symptom relief for adults with major depressive disorder; may include devices with regulatory breakthrough designations.","color":3,"productNames":["Closed-Loop tACS Device"]},{"name":"Research-grade transcranial electrical stimulation platforms","description":"High-powered, portable platforms that deliver tACS, tDCS and custom waveforms with double-blind capable study management for clinical trials and neuroscience research.","color":4,"productNames":["XCSITE-RD"]}],"faq":[],"comparisons":[],"sources":[{"url":"https://epii.com","text":"Electromedical Products International, Inc."},{"url":"https://alpha-stim.com/","text":"Alpha-Stim"},{"url":"https://epii.com/breakthrough-device/","text":"Closed-Loop tACS Device"}]}